|
Leuprolide Acetate Clinical Trials
5 actively recruiting trials across 4 locations
▼ -1 trial since August 2026
Also known as: A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard +24 more
Pipeline
Phase 2: 3Phase 3: 2
Top Sponsors
- The Methodist Hospital Research Institute1
- SWOG Cancer Research Network1
- Peking University First Hospital1
- ECOG-ACRIN Cancer Research Group1
- City of Hope Medical Center1
Indications
- Cancer5
- Stage IVB Prostate Cancer AJCC v83
- Stage IVA Prostate Cancer AJCC v82
- Stage IV Prostate Cancer AJCC v82
- Salivary Gland Neoplasm Duct1
Other1 trial
Anchorage, Alaska1 trial
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Anchorage Associates in Radiation Medicine
Phase 3
Gilbert, Arizona1 trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Banner MD Anderson Cancer Center
Phase 3
Duarte, California1 trial
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
City of Hope Medical Center
Phase 2
Houston, Texas1 trial
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
Houston Methodist Hospital
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.